We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCYX icon
351
SCYNEXIS
SCYX
$51.6M
$1.14M 0.02%
48,252
-24,957
-34% -$583K
LRMR icon
352
Larimar Therapeutics
LRMR
$436M
$1.14M 0.02%
363,505
+151,011
+71% +$616K
THRX
353
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$1.13M 0.02%
121,452
+10,737
+10% +$106K
VSTM icon
354
Verastem
VSTM
$519M
$1.12M 0.02%
150,904
+103,677
+220% +$720K
KPTI icon
355
Karyopharm Therapeutics
KPTI
$44.2M
$1.09M 0.02%
40,447
+860
+2% +$37K
EWTX icon
356
Edgewise Therapeutics
EWTX
$4.78B
$1.08M 0.02%
139,858
+6,890
+5% +$58.1K
DISH
357
PUT
DELISTED
DISH Network Corp.
DISH
$1.08M 0.02%
126,400
– –
DCPH
358
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.08M 0.02%
76,737
+18,042
+31% +$258K
CABA icon
359
Cabaletta Bio
CABA
$450M
$1.05M 0.02%
81,332
+36,332
+81% +$394K
CP icon
360
Canadian Pacific Kansas City
CP
$79.3B
$1.05M 0.02%
+12,985
New +$1.03M
MTCH icon
361
Match Group
MTCH
$8.4B
$1.05M 0.02%
25,000
+18,260
+271% +$668K
MEOH icon
362
Methanex
MEOH
$4.21B
$1.03M 0.02%
+25,000
New +$1.08M
SKIL icon
363
Skillsoft
SKIL
$72.1M
$1.03M 0.02%
41,682
– –
CPAY icon
364
Corpay
CPAY
$26B
$1.03M 0.02%
+4,100
New +$935K
CRNX icon
365
Crinetics Pharmaceuticals
CRNX
$8.9B
$1.01M 0.02%
56,153
+22,732
+68% +$453K
BKI
366
DELISTED
Black Knight, Inc. Common Stock
BKI
$975K 0.02%
16,329
+12,169
+293% +$683K
HWEL
367
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$950K 0.02%
92,441
-2,084
-2% -$21.3K
ATXS
368
DELISTED
Astria Therapeutics
ATXS
$950K 0.02%
+114,000
New +$1.32M
EVLVW
369
DELISTED
Evolv Technologies Warrant
EVLVW
$943K 0.02%
693,200
-15,685
-2% -$15.2K
ACAH
370
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$936K 0.02%
90,632
-2,042
-2% -$20.8K
RZLT icon
371
Rezolute
RZLT
$453M
$935K 0.02%
472,307
+41,832
+10% +$86.2K
STAA icon
372
STAAR Surgical
STAA
$1.15B
$928K 0.02%
17,650
-8,965
-34% -$546K
ARE icon
373
Alexandria Real Estate Equities
ARE
$8.34B
$925K 0.02%
8,150
+870
+12% +$104K
TSLA icon
374
Tesla
TSLA
$1.26T
$916K 0.02%
3,500
+2,500
+250% +$500K
CGEM icon
375
Cullinan Oncology
CGEM
$1.16B
$915K 0.02%
+85,000
New +$903K
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.